| scholarly article | Q13442814 |
| P50 | author | Tapas Nayak | Q42713223 |
| P2093 | author name string | Yin Zhang | |
| Kai Yang | |||
| Hao Hong | |||
| Weibo Cai | |||
| Zhuang Liu | |||
| Charles P Theuer | |||
| Hector F Valdovinos | |||
| Todd E Barnhart | |||
| Sixiang Shi | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Renal clearance of quantum dots | Q24657265 | ||
| Electric Field Effect in Atomically Thin Carbon Films | Q26778398 | ||
| The rise of graphene | Q28290805 | ||
| Positron emission tomography (PET) imaging with (18)F-based radiotracers | Q28716029 | ||
| Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA | Q28741667 | ||
| Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Multimodality molecular imaging of CD105 (Endoglin) expression | Q30476445 | ||
| Targeting of drugs and nanoparticles to tumors | Q33751710 | ||
| The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. | Q34101262 | ||
| Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody | Q34545866 | ||
| Molecular imaging of cancer with positron emission tomography | Q34810431 | ||
| Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab | Q35646547 | ||
| In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene | Q35854802 | ||
| In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene | Q35856996 | ||
| Graphene: a versatile nanoplatform for biomedical applications | Q36035392 | ||
| ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. | Q36185354 | ||
| A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer | Q36205086 | ||
| (18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge | Q36337213 | ||
| (18)F-FDG PET in sarcoma treatment response imaging. | Q36337223 | ||
| How to study optimal timing of PET/CT for monitoring of cancer treatment | Q36337232 | ||
| Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. | Q36406701 | ||
| Nanoplatforms for targeted molecular imaging in living subjects | Q36974486 | ||
| Endoglin (CD105): a marker of tumor vasculature and potential target for therapy | Q37125562 | ||
| Multimodality molecular imaging of tumor angiogenesis | Q37181539 | ||
| Molecular imaging and therapy of cancer with radiolabeled nanoparticles | Q37367335 | ||
| Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours | Q37610628 | ||
| Graphene-based nanomaterials and their electrochemistry | Q37771873 | ||
| Endoglin-Targeted Cancer Therapy | Q37804900 | ||
| Graphene in biomedicine: opportunities and challenges. | Q37850816 | ||
| Graphene-based materials: synthesis, characterization, properties, and applications | Q37883254 | ||
| Nano-graphene in biomedicine: theranostic applications. | Q38051522 | ||
| A roadmap for graphene. | Q38051580 | ||
| The clinical use of PET with (11)C-acetate. | Q38058333 | ||
| Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy | Q39561967 | ||
| Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors | Q39831476 | ||
| Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging | Q40025490 | ||
| Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature | Q40066441 | ||
| Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects | Q40293849 | ||
| Chemically Derived, Ultrasmooth Graphene Nanoribbon Semiconductors | Q56639728 | ||
| In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice | Q81697594 | ||
| In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice | Q82912017 | ||
| Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles | Q83542174 | ||
| Materials science. Carbon sheets an atom thick give rise to graphene dreams | Q83834206 | ||
| P433 | issue | 12 | |
| P921 | main subject | graphene | Q169917 |
| P304 | page(s) | 3002-3009 | |
| P577 | publication date | 2013-01-29 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Tumor vasculature targeting and imaging in living mice with reduced graphene oxide | |
| P478 | volume | 34 |
| Q47137759 | A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles |
| Q48653265 | A graphene quantum dot-based FRET system for nuclear-targeted and real-time monitoring of drug delivery |
| Q52675634 | Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. |
| Q59799280 | Biomedical Applications of Graphene-Based Structures |
| Q26827998 | Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging |
| Q38450511 | Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug |
| Q26783225 | Current applications of graphene oxide in nanomedicine |
| Q30759992 | Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles. |
| Q33687218 | Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy |
| Q34792343 | Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide. |
| Q58560988 | General synthesis of silica-based yolk/shell hybrid nanomaterials and tumor vasculature targeting |
| Q35957660 | Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain |
| Q26860274 | Graphene as cancer theranostic tool: progress and future challenges |
| Q38815275 | Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells |
| Q38413308 | Graphene-based nanomaterials as molecular imaging agents |
| Q37202881 | Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. |
| Q35788352 | ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment |
| Q58582293 | In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem |
| Q37327759 | In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. |
| Q34446399 | In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles |
| Q37624855 | Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery |
| Q36094945 | In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide |
| Q35153888 | Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy |
| Q37033916 | Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging. |
| Q48533196 | Mesoporous Carbon Nanospheres as a Multifunctional Carrier for Cancer Theranostics |
| Q89801078 | Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach |
| Q58234437 | Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors |
| Q98893613 | Multi-functionalised graphene nanoflakes as tumour-targeting theranostic drug-delivery vehicles |
| Q90505092 | Multi-parameter MRI to investigate vasculature modulation and photo-thermal ablation combination therapy against cancer |
| Q92938834 | Multifunctional Carbon-Based Nanomaterials: Applications in Biomolecular Imaging and Therapy |
| Q38247299 | Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments. |
| Q34216877 | New radiotracers for imaging of vascular targets in angiogenesis-related diseases |
| Q38781032 | Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers. |
| Q37558853 | Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy |
| Q38926681 | Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics |
| Q34446108 | Positron emission tomography image-guided drug delivery: current status and future perspectives |
| Q37425491 | Preparation and functionalization of graphene nanocomposites for biomedical applications |
| Q38751716 | Radio-graphene in Theranostic Perspectives |
| Q37131224 | Radio-nanomaterials for biomedical applications: state of the art |
| Q47447811 | Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging |
| Q39236622 | Recent advances in carbon based nanosystems for cancer theranostics. |
| Q38959097 | Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines |
| Q35079462 | Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting. |
| Q39233122 | Reproductive toxicity of nanoscale graphene oxide in male mice |
| Q36839885 | Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy |
| Q26853158 | Surface engineering of graphene-based nanomaterials for biomedical applications |
| Q26745949 | Synthesis, toxicity, biocompatibility, and biomedical applications of graphene and graphene-related materials |
| Q41953738 | Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics |
| Q35816600 | The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo. |
| Q30354655 | Theranostic Probes for Targeting Tumor Microenvironment: An Overview. |
| Q34178035 | Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging |
| Q30427860 | Toxicology of chemically modified graphene-based materials for medical application |
| Q36425431 | Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor |
| Q34019838 | Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials |
| Q38292327 | Two-dimensional graphene analogues for biomedical applications. |
| Q34650180 | VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. |
Search more.